Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Pimavanserin on Aggression and Social Cognition.

NCT05895513 is registered in ClinicalTrials.gov with Ohio State University as lead sponsor.

NCT NCT05895513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05895513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Pimavanserin on Aggression and Social Cognition.
Lead sponsor
Ohio State University
Phase
Phase 2
Overall status
Recruiting
Start date
August 1, 2024
Completion date
January 31, 2028
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intermittent explosive disorder